NEUSOFT XIKANG HOLDINGS INC. (HK:9686)
:9686
9686 Stock Chart & Stats
HK$0.90
HK$0.07(8.97%)
At close: 4:00 PM EST
HK$0.90
HK$0.07(8.97%)
Day’s Range― - ―
52-Week RangeHK$0.67 - HK$1.16
Previous CloseN/A
Volume78.50K
Average Volume (3M)60.92K
Market Cap
HK$707.18M
Enterprise ValueHK$651.36M
Total Cash (Recent Filing)HK$703.42M
Total Debt (Recent Filing)HK$520.84M
Price to Earnings (P/E)―
Beta0.27
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding841,876,830
10 Day Avg. Volume65,850
30 Day Avg. Volume60,916
Financial Highlights & Ratios
PEG Ratio0.33
Price to Book (P/B)2.17
Price to Sales (P/S)1.51
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Cash GenerationOperating cash flow turning positive and increasing into 2025 represents a durable shift in cash-generation capacity. Sustained positive OCF can fund working capital, reduce near-term refinancing needs, and provide a base for measured reinvestment or gradual deleveraging if management maintains cash discipline over multiple quarters.
Balance-sheet RepairRestoration of positive equity is a structural improvement that enhances solvency and creditor confidence. A repaired balance sheet lowers bankruptcy risk, improves access to capital and supplier terms, and provides a more stable base for executing medium-term recovery plans, even while leverage remains elevated.
Narrowing Losses / Improving Profitability TrendMaterial narrowing of losses versus prior years indicates the firm is moving toward break-even. If cost discipline and modest revenue stabilization persist, improving margins and positive EPS growth could convert higher gross profit into sustainable operating profitability over several quarters, supporting long-term viability.
Bears Say
Contracting RevenueTwo consecutive years of material revenue decline undermine operating leverage and make margin recovery harder. Continued top-line contraction reduces cash flow headroom, limits reinvestment ability and raises the bar for returning to sustainable profitability without a clear, lasting revenue inflection or new growth initiatives.
Meaningful LeverageDebt exceeding equity and a ~1.58 debt-to-equity ratio constrain strategic flexibility and raise refinancing risk. With volatile free cash flow, high leverage increases interest burden and vulnerability to adverse revenue trends, meaningful risks that require sustained cash generation or explicit deleveraging actions to mitigate.
Ongoing Net LossesPersistent operating losses mean the company cannot reliably self-fund growth or fully restore capital buffers. Even with improving cash flow, continued negative net income necessitates external financing or asset adjustments, which can dilute capital or limit strategic options unless structural margins improve consistently.
NEUSOFT XIKANG HOLDINGS INC. News
9686 FAQ
What was NEUSOFT XIKANG HOLDINGS INC.’s price range in the past 12 months?
NEUSOFT XIKANG HOLDINGS INC. lowest stock price was HK$0.67 and its highest was HK$1.16 in the past 12 months.
What is NEUSOFT XIKANG HOLDINGS INC.’s market cap?
NEUSOFT XIKANG HOLDINGS INC.’s market cap is HK$707.18M.
When is NEUSOFT XIKANG HOLDINGS INC.’s upcoming earnings report date?
NEUSOFT XIKANG HOLDINGS INC.’s upcoming earnings report date is Aug 27, 2026 which is in 143 days.
How were NEUSOFT XIKANG HOLDINGS INC.’s earnings last quarter?
NEUSOFT XIKANG HOLDINGS INC. released its earnings results on Mar 19, 2026. The company reported HK$0.013 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.013.
Is NEUSOFT XIKANG HOLDINGS INC. overvalued?
According to Wall Street analysts NEUSOFT XIKANG HOLDINGS INC.’s price is currently Overvalued.
Does NEUSOFT XIKANG HOLDINGS INC. pay dividends?
NEUSOFT XIKANG HOLDINGS INC. does not currently pay dividends.
What is NEUSOFT XIKANG HOLDINGS INC.’s EPS estimate?
NEUSOFT XIKANG HOLDINGS INC.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NEUSOFT XIKANG HOLDINGS INC. have?
NEUSOFT XIKANG HOLDINGS INC. has 841,876,830 shares outstanding.
What happened to NEUSOFT XIKANG HOLDINGS INC.’s price movement after its last earnings report?
NEUSOFT XIKANG HOLDINGS INC. reported an EPS of HK$0.013 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5%.
Which hedge fund is a major shareholder of NEUSOFT XIKANG HOLDINGS INC.?
Currently, no hedge funds are holding shares in HK:9686
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NEUSOFT XIKANG HOLDINGS INC.
Xikang Cloud Hospital Holdings, Inc. engages in the development of a city-specific cloud hospital platform. It operates through the following segments: Cloud Hospital Platform Services, Internet Medical Services, Health Management Services, and Smart Healthcare Products. The Cloud Hospital Platform Services segment offers technology solutions to local governments, medical institutions, and insurers. The Internet Medical Services segment includes online hospital, remote medical, smart family doctor, and internet home care services. The Health Management Services segment consists of comprehensive health management and chronic disease management services. The Smart Healthcare Products segment sells smart healthcare products to local governments, primary medical institutions, corporations, and individuals. The company was founded on May 12, 2011 and is headquartered in Shanghai, China.
Technical Analysis
Yidu Tech, Inc.
―
MicroPort CardioFlow Medtech Corp.
―
Suzhou Basecare Medical Corp. Ltd. Class H
―
Beijing Airdoc Technology Co. Ltd. Class H
―
Shanghai Conant Optical Co. Ltd. Class H
―